InvestorsHub Logo
Followers 16
Posts 296
Boards Moderated 0
Alias Born 10/20/2009

Re: None

Sunday, 07/28/2019 3:01:40 PM

Sunday, July 28, 2019 3:01:40 PM

Post# of 403131
I just sent an email to several staff members of "Endpoints News" a pharma news journal:

I'd like to call to your attention the recent press release of IPIX, Innovation Pharmaceuticals, regarding their deal with the Italian pharma co., Alphasigma:
INNOVATION PHARMACEUTICALS ANNOUNCES LICENSE AGREEMENT WITH ALFASIGMA S.P.A. FOR THE DEVELOPMENT AND COMMERCIALIZATION OF BRILACIDIN IN ULCERATIVE PROCTITIS/ULCERATIVE PROCTOSIGMOIDITIS
Brilacidin is been successful in several studies. I hope you will investigate and report about this promising development.
Disclosure: I am a shareholder of IPIX.
Thanks,
gh
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News